Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data
Alcohol, Clinical and Experimental Research · 2026-11 · 50 (11)
DOI: 10.1111/acer.70416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, online erschienen am 09.11.2026. Verfasst von Wanzhu Tu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Diseases, Alcoholic. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (Originalsprache)
Background
Alcohol‐associated liver disease (ALD) is a leading indication for liver transplantation (LT) in the United States. While post‐transplant outcomes are well established, the relative survival benefit of LT compared to non‐LT remains underdefined.
Methods
Using Optum's de‐identified Clinformatics Data Mart Database, we identified adults with ALD between 2017 and 2024. We used logistic regression to evaluate factors associated with LT, and Cox regression to compare survival between LT recipients and non‐recipients.
Results
Among 373,025 patients with ALD, 3453 underwent LT. Female sex (adjusted OR = 0.805; 95% Confidence Interval (CI): 0.750–0.866), African‐American race (adjusted OR = 0.542; 95% CI: 0.462–0.636), older age, and non‐liver comorbidities, and all types of metastatic cancer were associated with lower odds of LT; non‐metastatic liver cancer, however, was associated with increased odds of LT (adjusted OR = 4.147; 95% CI: 3.659–4.699). The 8‐year restricted mean survival time was 2600 days (~7.12 years) for LT recipients and 1799 days (~4.93 years) for nonrecipients. The median survival among deceased patients was 1000 days with LT vs. 355 days without LT. LT was associated with a lower adjusted mortality risk (HR, 0.365; 95% CI: 0.333–0.401).
Conclusion
LT confers a substantial survival advantage for patients with ALD, beyond what is achieved without transplantation. However, significant sex and race‐based disparities persist, underscoring the need for policy interventions to promote equitable access and optimized candidate selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biostatistics & Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Roudebush Veterans Administration Medical Center, Indianapolis, Indiana, USA.
ORCID-Profile: Wanzhu Tu, Lauren Nephew, Yining Li, Yang Li, Chi M Nguyen, Jing Su, Naga Chalasani, Samer Gawrieh, Suthat Liangpunsakul
Förderung
- NIAAA NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Zitieren
APA
Tu, W., Nephew, L., Li, Y., Jiang, S., Li, Y., Nguyen, C. M., Su, J., Chalasani, N., Gawrieh, S., & Liangpunsakul, S. (2026). Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data. Alcohol, Clinical and Experimental Research, 50(11). https://doi.org/10.1111/acer.70416
Vancouver
Tu W, Nephew L, Li Y, Jiang S, Li Y, Nguyen CM, et al. Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data. Alcohol, Clinical and Experimental Research. 2026;50(11). doi:10.1111/acer.70416
BibTeX
@article{Tu2026,
author = {Tu, Wanzhu and Nephew, Lauren and Li, Yining and Jiang, Shihui and Li, Yang and Nguyen, Chi M and Su, Jing and Chalasani, Naga and Gawrieh, Samer and Liangpunsakul, Suthat},
title = {Long‐Term Survival of Liver Transplantation in Alcohol‐Associated Liver Disease: Insights From National Claims Data},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
volume = {50},
number = {11},
doi = {10.1111/acer.70416}
}
EUVIMED